Selank
Anxiolytic heptapeptide. Solo framework separating signal from placebo; objective metrics matter.
- Half-life
- 30 min
- Out of system
- ~3 h
- Route
- Intranasal
- Level
- Intermediate
Very short-acting — protocols dose 1–2× a day. After the last dose, roughly 97% has cleared in ~3 h (five half-lives) — the window that matters for washouts, bloodwork and surgery.
What Selank is used for
- Intranasal anxiolytic — reported calm + clarity without sedation
- Russian clinical history for anxiety + cognitive symptoms
- Tolerability is excellent in available data
How it's typically used
Research range: 250–500 mcg intranasal, 1–3 sprays daily.
What to watch for
- Separation from placebo is hard — track objective metrics
- Russian clinical methodology isn't Western-standard
- Long-term human safety in the wider population is limited
About Other research compounds
- What they are
- Nootropics, metabolic agents, and research compounds that don't fit the other classes.
- How they're run
- Route and schedule vary widely — check the individual entry.
- What to watch
- This is the least-characterised corner of the atlas. Read the full guide, and treat anything without published human data as exactly that.
Full guide
Selank Alone: A Focused Tracking Guide for the Anxiolytic Heptapeptide
A dedicated tracking framework for Selank used on its own, separating its anxiolytic signal from placebo and lifestyle noise.
Other other research compounds
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.